Keywords: Sanofi, Taxotere, biosimilar, Australia, hospira, Apotex, Amgen

Sanofi facing generic Taxotere competition in USA; first biosimilar cleared in Australia

Article | 30 September 2010

Print This

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in